Twelfth Magpie Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

Market Data powered by QuoteMedia. Copyright © 2026. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

AstraZeneca Plc (LSE: AZN)
Latest News

Investing Articles

Can AstraZeneca plc’s Share Price Return To 3,625p?

| Rupert Hargreaves

Will AstraZeneca plc (LON: AZN) be able to return to its previous highs?

Read more »

Investing Articles

The Warren Buffett Bear Case For AstraZeneca plc

| G A Chester

A Buffett fan considers the investment case for AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

AstraZeneca plc Could Be Worth 3915p

| Peter Stephens

Shareholders in AstraZeneca plc (LON: AZN) could enjoy gains of 18.5% plus a generous dividend. Here’s why…

Read more »

Investing Articles

Why AstraZeneca plc Will Be One Of 2013’s Winners

| Alan Oscroft

It's a close run for AstraZeneca plc (LON: AZN) as we approach the end of the year.

Read more »

Investing Articles

A SWOT Analysis Of AstraZeneca Plc And GlaxoSmithKline plc

| David O'Hara

What are the key factors affecting the investment proposition at pharmaceutical giants GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN)?

Read more »

Investing Articles

Angels vs Devils: Should You Invest In AstraZeneca plc?

| Royston Wild

Royston Wild considers the pros and cons of investing in AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

This Model Suggests AstraZeneca plc Could Deliver A 6.3% Annual Return

| Roland Head

Roland Head explains why AstraZeneca plc (LON:AZN) could deliver a 6.3% annual return over the next few years.

Read more »

Company Comment

AstraZeneca Plc’s Turnaround Story Hasn’t Started Yet

| Keith Speights

The turnaround story at AstraZeneca plc (LON:AZN) may require a good deal more time to even begin...

Read more »

Investing Videos

Is AstraZeneca Plc A Good Way To Play Emerging Markets?

| Owain Bennallack

VIDEO: One Fool weighs up the emerging-market potential of AstraZeneca plc (LON:AZN).

Read more »

Company Comment

Betting On AstraZeneca plc’s Drug Pipeline

| Owain Bennallack

What’s caused £41 billion drugs maker AstraZeneca plc (LON:AZN) to become afflicted by a seemingly interminable wasting disease?

Read more »

Investing Videos

A Closer Look At AstraZeneca plc

| Jill Ralph

VIDEO: Two Fools analyse AstraZeneca plc (LON: AZN).

Read more »

Company Comment

Earnings Drop 16% At AstraZeneca Plc

| Nate Weisshaar

Investing the future while revenues fall takes its toll on the bottom line at AstraZeneca plc (LON:AZN).

Read more »